logologo
QuantliQuantli

Agios Pharmaceuticals Inc

AGIO

NASDAQ

Biotechnology

$33.56

USD

+0.09 (+0.27%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $2.00B

Volume 1.1M

Price Target

$31.00$40.00

USD

The 3 analysts offering 1-year price forecasts have a max estimate of $40.00 and a min estimate of $31.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$36.67

-$3.5 vs prior

Implied Upside

+9.3%

-10.4% vs prior

Analyst Covering

3

-3 vs prior period

Consensus

Hold

Unchanged vs prior

Signal Quality

Consensus Freshness

33%

Many ratings are older - consensus may be less current

Analyst Agreement

Moderate

Targets show moderate spread across analysts

Mean vs Median

$2.33 Gap

Median $39.00 vs avg $36.67 - a few cautious outliers are pulling the average down

Analyst Consensus

Strong Sell

Hold

Strong Buy

Hold

2 Buy

1 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

2

Hold

1

Sell

0

Strong Sell

0

3 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Gregory Renza

Truist Securities

Buy

Maintained

2 weeks ago

Plus
Plus
Plus

Tessa Romero

JP Morgan

Hold

Maintained

2 months ago

Plus
Plus
Plus

Greg Harrison

Scotiabank

Buy

Maintained

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

ADMA

ADMA Biologics Inc

$9.47

+0.6%

ZBIO

Zenas Biopharma Inc

$29.51

+1.1%

DMRA

Damora Therapeutics Inc

$31.04

+1.0%

STOK

Stoke Therapeutics Inc

$31.27

-0.1%

TSHA

Taysha Gene Therapies Inc

$5.95

-0.7%

SRPT

Sarepta Therapeutics Inc

$18.10

-1.7%

ANAB

AnaptysBio Inc

$58.47

+4.4%

VRDN

Viridian Therapeutics Inc

$22.08

+0.4%

SNDX

Syndax Pharmaceuticals Inc

$19.84

+4.0%

GENB

Generate Biomedicines Inc

$15.64

+4.1%